CAPE CANAVERAL, Fla., April 19, 2024 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq.
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Presentation will address the Company’s clinical data in Parkinson’s diseaseCAPE CANAVERAL, Fla., March 28, 2024 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of.
CAPE CANAVERAL, Fla., March 27, 2024 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth.
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.